CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 39 enrolled
Drug / intervention
electrical stimulation pain therapy +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01196442
NCT01196442N/ACompleted
CompareCT.gov

An Expanded Trial of MC5-A Calmare Therapy in the Treatment of Cancer Pain Syndromes and Chronic Chemotherapy-Induced Peripheral Neuropathy Including Pain and Numbness

Virginia Commonwealth University·interventional·Posted Sep 8, 2010·Updated Aug 23, 2013

In Brief

A clinical study evaluating electrical stimulation pain therapy and questionnaire administration for Cancer-related Problem/Condition and 3 related conditions. Completed, enrolled 39 participants across 1 site.

Detailed Summary

RATIONALE: Electrical stimulation pain therapy may help relieve chronic pain and numbness caused by chemotherapy. PURPOSE: This pilot trial studies electrical stimulation pain therapy in treating chronic pain and numbness caused by chemotherapy in patients with cancer.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCancer-related Problem/Condition, Neurotoxicity, Pain, Peripheral Neuropathy
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedSep 8, 2010
Enrollment StartSep 1, 2010
Primary CompletionSep 1, 2012
Study CompletionJan 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 15.8 years ago

Interventions

electrical stimulation pain therapyother

Electrical stimulation pain therapy for 45 minutes on Day 1, then 30 minutes Days 2-10

questionnaire administrationother

Brief Pain Inventory questionnaire administration at baseline, weekly, then monthly for 3 months